Positron Emission Tomography or PET scanners are medical imaging systems that help physicians detect cancer and other diseases in the early stages by producing three-dimensional images of metabolic activity inside the body. PET scans uses radiotracers that emit positrons to generate the images and are highly preferred over CT and MRI scans for better accuracy in cancer diagnosis, staging and treatment monitoring.
The global Positron Emission Tomography Scanners Market is estimated to be valued at US$ 2.5 Bn in 2023 and is expected to exhibit a CAGR of 6.6% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends: The key trend propelling the growth of the PET scanners market is the increased demand for early disease detection. PET scanning helps detect cancer and other diseases at an early stage when the chances of successful treatment are higher. With rising cancer prevalence across the world, healthcare providers are increasingly relying on PET scans for accurate cancer diagnosis and staging. According to the World Health Organization, cancer burden is expected to grow to 27.5 million new cancer cases and 16.3 million cancer deaths by 2040. This rising disease prevalence is driving the need for better diagnostic tools like PET scanners for early detection and management of critical health conditions.
SWOT Analysis
Strength: Positron Emission Tomography scanners provide accurate diagnosis of cancers and other diseases. It has high sensitivity and specificity for detecting tumors and metastatic lesions.
Weakness: PET scans have higher cost compared to other diagnostic imaging modalities. It also exposes patients to radiation.
Opportunity: Rising burden of cancer and other chronic diseases across the world increasing the demand for PET scans. Growing applications in drug development and research also opens opportunities.
Threats: Strict regulations pertaining to radiation exposure. Competition from other emerging diagnostic technologies.
Key Takeaways
The global Positron Emission Tomography scanners market is expected to witness high growth over the forecast period of 2023 to 2030.
Regional analysis: The North American region currently dominates the market due to growing cases of cancer and availability of advanced healthcare facilities. Asia Pacific is expected to show rapid growth due to increasing healthcare spending and large patient population.
Key players: Key players operating in the Positron Emission Tomography scanners market are Positron Corporation (US), CellSight Technologies. (US), RefleXion. (Canada), Clarity Pharmaceuticals (Australia), PETsys Electronics SA (Portugal), Blue Earth Diagnostics Limited. (UK), Qubiotech Health Intelligence S.L. (Spain), Advanced Accelerator Applications (France), Lily. (US), Agfa-Gevaert Group. (Belgium), CMR Naviscan. (US), Neusoft Corporation (China), Siemens (Germany), Segamicorp (US), ONCOVISION. (Spain), Modus Medical Devices Inc. (Canada), Radiology Oncology Systems (US), TOSHIBA CORPORATION (Japan), and General Electric Company (US), among others.
*Note:
- Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
